Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-19663.3China
BQ.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
BQ.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FA.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FA.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FA.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used